Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Highlights from the Tenth International Workshop on HIV Persistence during Therapy, December 13-16, 2022, Miami, Florida-USA
  2. Archin, N; Bar, K J; Burdo, T; Caskey, M; Chahroudi, A; Farzan, M; Ho, Y-C; Jones, R B; Kearney,Mary; Kuritzkes, D; Margolis, D; Martinez-Picado, J; Okoye, A; Salgado, M; Stevenson, Mario
  3. Journal of Virus Eradication. 2023, Mar; 9(1): 100315.
  1. 2.   Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
  2. Lian, Xiaodong; Seiger, Kyra W; Parsons, Elizabeth M; Gao, Ce; Sun, Weiwei; Gladkov, Gregory T; Roseto, Isabelle C; Einkauf, Kevin B; Osborn, Matthew R; Chevalier, Joshua M; Jiang, Chenyang; Blackmer, Jane; Carrington,Mary; Rosenberg, Eric S; Lederman, Michael M; McMahon, Deborah K; Bosch, Ronald J; Jacobson, Jeffrey M; Gandhi, Rajesh T; Peluso, Michael J; Chun, Tae-Wook; Deeks, Steven G; Yu, Xu G; Lichterfeld, Mathias
  3. Cell Host & Microbe. 2022, Dec 28; 31
  1. 3.   Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
  2. Ivison, Geoffrey T; Vendrame, Elena; Martínez-Colón, Giovanny J; Ranganath, Thanmayi; Vergara, Rosemary; Zhao, Nancy Q; Martin,Pat; Bendall, Sean C; Carrington,Mary; Cyktor, Joshua C; McMahon, Deborah K; Eron, Joseph; Jones, R Brad; Mellors, John W; Bosch, Ronald J; Gandhi, Rajesh T; Holmes, Susan; Blish, Catherine A
  3. Frontiers in Cellular and Infection Microbiology. 2022 12: 757846.
  1. 4.   Clonal Expansion of Infected CD4+T Cells in People Living with HIV
  2. Coffin, John M.; Hughes, Stephen H.
  3. Viruses. 2021, Oct 15; 13(10):
  1. 5.   Development of a reverse transcription droplet digital PCR (RT-ddPCR) assay for sensitive detection of simian immunodeficiency virus (SIV)
  2. Long, Samuel; Berkemeier, Brian
  3. Virology Journal. 2021, Feb 15; 18(1):
  1. 6.   Evaluating a New Class of AKT/mTOR Activators for HIV Latency-Reversing Activity Ex Vivo and In Vivo
  2. Gramatica, Andrea; Schwarzer, Roland; Brantley, William; Varco-Merth, Benjamin; Sperber, Hannah S.; Hull, Philip A.; Montano, Mauricio; Migueles, Stephen A.; Rosenthal, Danielle; Hogan, Louise E.; Johnson, Jeffrey R.; Packard, Thomas A.; Grimmett, Zachary W.; Herzig, Eytan; Besnard, Emilie; Nekorchuk, Michael; Hsiao, Feng; Deeks, Steven G.; Snape, Michael; Kiernan, Bernard; Roan, Nadia R.; Lifson,Jeffrey; Estes, Jacob D.; Picker, Louis J.; Verdin, Eric; Krogan, Nevan J.; Henrich, Timothy J.; Connors, Mark; Ott, Melanie; Pillai, Satish K.; Okoye, Afam A.; Greene, Warner C.
  3. Journal of Virology. 2021, Feb 03; 95(8):
  1. 7.   Intact HIV proviruses persist in children 7-9 years after initiation of ART in the first year of life
  2. Katusiime, Mary Grace; Halvas, Elias K; Wright, Imogen; Joseph, Kevin; Bale,Michael; Kirby-McCullough, Bronwyn; Engelbrecht, Susan; Shao,Wei; Hu,Wei-Shau; Cotton, Mark F; Mellors, John W; Kearney,Mary; van Zyl, Gert U
  3. Journal of virology. 2020, FEB; 94(4):
  1. 8.   Transplantation of CCR5 Delta 32 Homozygous Umbilical Cord Blood in a Child With Acute Lymphoblastic Leukemia and Perinatally Acquired HIV Infection
  2. Rothenberger, Meghan; Wagner, John E; Haase, Ashley; Richman, Douglas; Grzywacz, Bartosz; Strain, Matthew; Lada, Steven; Estes, Jake; Fletcher, Courtney V; Podany, Anthony T; Anderson, Jodi; Schmidt, Thomas; Wietgrefe, Steve; Schacker, Timothy; Verneris, Michael R
  3. Open forum infectious diseases. 2018, May; 5(5): ofy090.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel